Should You Buy AstraZeneca plc (ADR) (AZN)?
Is AstraZeneca plc (ADR) (NYSE:AZN) a healthy stock for your portfolio? Investors who are in the know are getting more bullish.
Posts Tagged ‘NYSE:AZN’
Galena Biopharma Inc (GALE), Oncolytics Biotech, Inc. (USA) (ONCY): 2 Drugs With Acquisition Potential
Big pharmaceutical players, known as Big Pharma, depend on patents to fend of generic threats to their blockbuster drugs.
How AstraZeneca plc (ADR) (AZN) Measures Up as a GARP Investment
LONDON -- A popular way to dig out reasonably priced stocks with robust growth potential is through the "Growth at a Reasonable Price," or GARP, strategy.
AstraZeneca plc (ADR) (AZN), Select Medical Holdings Corporation (SEM), Meridian Bioscience, Inc. (VIVO): Three High Dividend Healthcare Stocks
The U.S. government has been consistently cutting rates for the last few years. The aim of this exercise is to jump start the sluggish U.S. economy.
AstraZeneca plc (ADR) (AZN): This Pharma Company Is Making the Right Moves
Mergers and acquisitions appear to be continuously reshaping the pharmaceuticals industry.
Amarin Corporation plc (ADR) (AMRN): This Drugmaker Should Go Fishing for a Marketing Partner
The biotechnology sector is rapidly evolving, and what was a near-guarantee of success of getting a drug approved by the Food and Drug Administration 10 years ago is no longer...
AstraZeneca plc (ADR) (AZN), Electronic Arts Inc. (EA): Stocks Are at All-Time Highs…Is it Time to Sell?
Unless you have a crystal ball, you can't time the market. So don't try it; just stay in the market as a whole.
AbbVie Inc (ABBV): Hedge Funds and Insiders Are Bullish, What Should You Do?
According to most market participants, hedge funds are assumed to be underperforming, old financial vehicles of yesteryear.
Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ): 5 Costliest Microbes in Financial History
The field of synthetic biology is still in its infancy, with many of the most promising companies residing outside of public markets, but make no mistake: The bioeconomy is on...
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): This Obesity Drugmaker Is Badly In Need of a Marketing Partner
As recently as a decade ago, the biggest hurdle for biotech companies wasn't competition from their peers or even the sale price of their drugs.
Amarin Corporation plc (ADR) (AMRN), AstraZeneca plc (ADR) (AZN): Right Drug Class, Wrong Company
We've been speculating for almost a year that Amarin Corporation plc (ADR) (NASDAQ:AMRN) would be purchased by AstraZeneca plc (ADR) (NYSE:AZN).
Amarin Corporation plc (ADR) (AMRN) News: Struggle, New Announcement & AstraZeneca Plc (AZN)’s Dominance
Amarin Corporation plc (ADR) (NASDAQ:AMRN) has been struggling a lot lately as retail channel prescription data for its EPA capsule Vascepa imply that the drug is starting to ...
The City News: InterContinental Hotels Group PLC (IHG), Barclays PLC (BARC), GlaxoSmithKline plc (GSK) & More
Editor's Note: Related tickers: JPMorgan Chase & Co.
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY), AbbVie Inc (ABBV): The 5 Highest-Paying Dividend Stocks in Big Pharma
Any investor looking for the highest-paying dividend stocks would do well to start in Big Pharma, where many of the top picks offer yields in excess of 3% or 4%.
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN): The Top Three Diseases Caused by Stress
Let's face it; we all dislike stress, but it's something we all live with to some degree.
Santarus, Inc. (SNTS) Is a Real Gas!
Investing in the stock market can sometimes be a gut wrenching experience. However, for investors in Santarus, Inc.
AstraZeneca plc (ADR) (AZN), BAE Systems PLC (ADR) (BAESY): Three Neil Woodford High-Yield Shares
LONDON -- Ace City investor Neil Woodford has thrashed the FTSE 100 over the last five, 10, and 15 years.
AstraZeneca plc (ADR) (AZN): Do Major Drug Manufacturers Have Room to Grow?
Major drug manufacturers are literally a market sector unto themselves.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) – Pick Your Poison: Overweight or High Cholesterol
Overweight and have high cholesterol? You may have to pick one to work on at a time, according to data from the lab of John Thyfault, an associate professor of nutrition and exercise...
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN): Statin Users May Have a Reason to Rejoice After This Data
Whether or not you've been keeping tabs, the American Society of Clinical Oncology's annual meeting is less than two weeks away.
MannKind Corporation (MNKD): Why Have Shares Moved?
MannKind Corporation (NASDAQ:MNKD) took one giant leap over the past few days.
AstraZeneca plc (ADR) (AZN): The Latest News
AstraZeneca plc (ADR) (NYSE:AZN)'s in a tight spot.
AstraZeneca plc (AZN): How Does It Stack Up?
LONDON -- Dividend income accounts for around two-thirds of total returns, the actual rate of return taking into account both capital and income appreciation.
AstraZeneca plc (ADR) (AZN): Where Investment Dollars Are Headed
As I noted 10 weeks ago, cancer statistics are both staggering and disappointing.
SolarCity Corp (SCTY), Exelixis, Inc. (EXEL): Watch These Stocks
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Edwards Lifesciences Corp (EW), Sarepta Therapeutics Inc (SRPT), Rigel Pharmaceuticals, Inc. (RIGL): April’s Unhealthiest Stocks
Leading health-care stocks have had a good start to the year, but all's not healthy in the world of medicine.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): FDA Approves Powerful New Cholesterol Drug
Merck & Co., Inc. (NYSE:MRK) gained Food and Drug Administration approval for its powerful new cholesterol drug Liptruzet, a combination of two already-approved drugs, Pfizer...
Merck & Co., Inc. (MRK) Down, Could’ve Fallen Worse
The problem was the other drugs didn't make up nearly enough of the Singulair loss.
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Merck & Co., Inc. (MRK): Post-Earnings Performance Questions
Merck & Co., Inc. (NYSE:MRK) stock could move up or down this week after the pharmaceutical company reports earnings on Wednesday.
Galena Biopharma Inc (GALE), Gilead Sciences, Inc. (GILD): Two Biopharmaceutical Companies Worth Buying
The biotechnology industry had a good time last year and the market expects the trend to continue in 2013 as well.
AstraZeneca plc (ADR) (AZN): Is It The Ultimate Stock Picker’s Share?
AstraZeneca plc (ADR) (NYSE:AZN) is the 12th biggest company in the FTSE 100. It is a true blue chip.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY): A New Diabetes Duo Emerges
That's the message from today's announcement that Pfizer Inc. (NYSE:PFE) is out-licensing its diabetes drug candidate ertugliflozin to Merck & Co., Inc. (NYSE:MRK).
AstraZeneca plc (ADR) (AZN), Exelixis, Inc. (EXEL), Pfizer Inc. (PFE) & Tackling Cancer: Thyroid Cancer’s Biggest Current and Upcoming Players
As I noted eight weeks ago, cancer statistics are both staggering and disappointing.
AstraZeneca plc (ADR) (AZN) Faces “Tremendous Operational Challenges”
LONDON -- Pharmaceutical group AstraZeneca plc (ADR) (NYSE:AZN) was in the headlines at the weekend after the Telegraph anonymously quoted a top-five shareholder speaking out...
Bristol Myers Squibb Co. (BMY): Growing Bigger and Better
Bristol Myers Squibb Co. (NYSE:BMY) has been in the spotlight for its so-called “desired” acquisitions and its size issues, along with patent expiration news.
AstraZeneca plc (AZN) & More: Three FTSE Shares Hitting New Highs
LONDON -- It's little more than a month since the FTSE 100 set a new five-year record of 6,534 points on March 12.
Alkermes Plc (ALKS), Pfizer Inc. (PFE), Eli Lilly & Co. (LLY): These Biotech Investors Are Far From Depressed
The drug produced a statistically significant improvement in three different rating scales for depression compared to placebo.
GlaxoSmithKline plc (ADR) (GSK): Why This Stock Beats AstraZeneca plc (ADR) (AZN) and Shire PLC (ADR) (SHPG)
LONDON -- After offering my pick of our telecom companies last week, today I'm turning my attention to the FTSE 100 Pharmaceuticals and Biotechnology sector.
Bristol Myers Squibb Co. (BMY): Is This Company Destined for Greatness?
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
General Electric Company (GE), WellPoint, Inc. (WLP): Five Ways Obamacare Will Succeed
With the passing of the Patient Protection and Affordable Care Act in 2010, also known in shorthand as Obamacare, lawmakers and President Obama ushered in the winds of change ...
AstraZeneca plc (ADR) (AZN): Hedge Funds are Bearish…What to Do?
Is AstraZeneca plc (ADR) (NYSE:AZN) worth your attention right now? The smart money is becoming less confident. The number of long hedge fund bets fell by 2 lately.
GlaxoSmithKline plc (ADR) (GSK) & Three Humongous Healthcare Stocks This Week
April showers might bring May flowers, but the first week of the new month has already seen several health-care stocks hit full bloom.
Johnson & Johnson (JNJ): This Company’s Biggest Drug Rivals
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Johnson & Johnson (JNJ), Rigel Pharmaceuticals, Inc. (RIGL): This Week in Biotech
With the SPDR S&P Biotech Index up 22% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
AstraZeneca plc (ADR) (AZN), Rigel Pharmaceuticals, Inc. (RIGL): Growing Aches and Pains Sink This Stock
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
AstraZeneca plc (ADR) (AZN): Why This Company, Punch Taverns, and Severfield-Rowen Should Beat the FTSE 100 Today
LONDON -- The FTSE 100 (INDEXFTSE:UKX) has slumped 1.2% to 6,269 points as of 8 a.m. EDT. The big fear last night was for weak U.S.
AstraZeneca plc (AZN), Tesla Motors Inc (TSLA) & More: Three Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): AbbVie Inc (ABBV) Insiders Are Buying, Should You?
AbbVie Inc (NYSE:ABBV) investors should be aware of an increase in hedge fund sentiment of late, and we'll compare the company to peers like GlaxoSmithKline plc (ADR) (NYSE:GSK...
Can AstraZeneca plc (ADR) (AZN) Outperform Merck & Co., Inc. (MRK)?
LONDON -- If you're interested in building a profitable, diversified portfolio, then you will often need to compare similar companies when choosing which share to buy next.
